Reduced Incidence of Acute Graft Versus Host Disease (GVHD) and Transplant-Related Mortality (TRM) with the Addition of Short-Course Mini-Dose Methotrexate (MTX) to Cyclosporine (CSA) as GVHD Prophylaxis Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).
暂无分享,去创建一个
N. Geller | H. Hedlin | R. Srinivasan | R. Childs | J. Barrett | Hisayuki Yokoyama | S. Srivastava | C. Bolan | T. Donohue | Aleah L. Smith | L. Cook | Catalina Ramos | R. Goodwin | Jennifer M. Karpovich